Mezzion Pharma Co.Ltd (140410) - Total Liabilities

Latest as of March 2026: ₩83.41 Billion KRW ≈ $56.53 Million USD

Based on the latest financial reports, Mezzion Pharma Co.Ltd (140410) has total liabilities worth ₩83.41 Billion KRW (≈ $56.53 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Mezzion Pharma Co.Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Mezzion Pharma Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See Mezzion Pharma Co.Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Mezzion Pharma Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Mezzion Pharma Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Pes Camanchaca SN:CAMANCHACA	Chile	CL$423.96 Million
Paysafe Ltd NYSE:PSFE	USA	$4.15 Billion
Beijing Capital International Airport Company Limited F:BJ1	Germany	€18.26 Billion
Aurelia Metals Ltd AU:AMI	Australia	AU$184.83 Million
Xperi Corp NYSE:XPER	USA	$535.82 Million
Henan Rebecca Hair Products Co Ltd SHG:600439	China	CN¥1.67 Billion
Thessaloniki Port Authority SA AT:OLTH	Greece	€76.05 Million
Sumber Global Energy Tbk Pt JK:SGER	Indonesia	Rp2.80 Trillion

Liability Composition Analysis (2012–2025)

This chart breaks down Mezzion Pharma Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 140410 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.47	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	5.38	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.84	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mezzion Pharma Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mezzion Pharma Co.Ltd (2012–2025)

The table below shows the annual total liabilities of Mezzion Pharma Co.Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩80.83 Billion ≈ $54.78 Million	+189.35%
2024-12-31	₩27.94 Billion ≈ $18.93 Million	-9.02%
2023-12-31	₩30.70 Billion ≈ $20.81 Million	+10.52%
2022-12-31	₩27.78 Billion ≈ $18.83 Million	+31.41%
2021-12-31	₩21.14 Billion ≈ $14.33 Million	+12.36%
2020-12-31	₩18.82 Billion ≈ $12.75 Million	+17.28%
2019-12-31	₩16.04 Billion ≈ $10.87 Million	-9.56%
2018-12-31	₩17.74 Billion ≈ $12.02 Million	-14.99%
2017-12-31	₩20.87 Billion ≈ $14.14 Million	-51.57%
2016-12-31	₩43.09 Billion ≈ $29.20 Million	+6.35%
2015-12-31	₩40.52 Billion ≈ $27.46 Million	+921.54%
2012-12-31	₩3.97 Billion ≈ $2.69 Million	--

About Mezzion Pharma Co.Ltd

KQ:140410 Korea Pharmaceuticals

Market Cap

$371.25 Million

₩547.82 Billion KRW

Market Cap Rank

#13948 Global

#444 in Korea

Share Price

₩64100.00

Change (1 day)

+0.63%

52-Week Range

₩36450.00 - ₩172700.00

All Time High

₩172700.00